Alert detail
LCD L36155: MolDX: Genetic Testing for Hypercoagulability / Thrombophilia (Factor V Leiden, Factor II Prothrombin, and MTHFR) — Noridian
What changed
New LCD for genetic testing could impact billing processes.
Who’s affected: Hematology billing teams · Effective: January 22, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 9 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.